TTA-Q6 is a selective T-type Ca 2+ channel antagonist, which can be used in the research of neurological disease
In Vitro
TTA-Q6 is a selective T-type Ca 2+ channel antagonist, with 14 nM and 590 nM in FLIPR depolarized assaay and FLIPR hyperpolarized assay. MCE has not independently confirmed the accuracy of these methods. They are for reference only.
